New-look Hologic "shifting from growth to value"
This article was originally published in Clinica
Executive Summary
Returning Hologic CEO Jack Cumming already seems to be having an impact, with the firm shifting its strategy to “emphasize return of capital over growth,” according to Jefferies analyst Raj Denhoy.